E Fund Management Co. Ltd. bought a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 29,310 shares of the company’s stock, valued at approximately $3,766,000.
Several other large investors have also recently added to or reduced their stakes in the company. Danske Bank A S bought a new position in shares of Merck KGaA in the 2nd quarter worth about $276,535,000. Great Lakes Advisors LLC acquired a new position in shares of Merck KGaA during the second quarter worth approximately $183,444,000. Tocqueville Asset Management L.P. acquired a new position in shares of Merck KGaA during the second quarter worth approximately $57,546,000. Edmond DE Rothschild Holding S.A. bought a new position in Merck KGaA in the 2nd quarter worth approximately $51,346,000. Finally, Danica Pension Livsforsikringsaktieselskab bought a new position in Merck KGaA in the 2nd quarter worth approximately $25,541,000. 0.10% of the stock is currently owned by institutional investors.
Merck KGaA Trading Up 4.5%
OTCMKTS:MKGAF opened at $167.38 on Thursday. Merck KGaA has a 1 year low of $116.68 and a 1 year high of $175.56. The stock has a market cap of $21.63 billion, a price-to-earnings ratio of 25.55 and a beta of 0.96. The business has a fifty day moving average of $162.50 and a 200-day moving average of $148.28. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
See Also
- Five stocks we like better than Merck KGaA
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
